Cargando…

Development and Effects of Influenza Antiviral Drugs

Influenza virus is a highly contagious zoonotic respiratory disease that causes seasonal outbreaks each year and unpredictable pandemics occasionally with high morbidity and mortality rates, posing a great threat to public health worldwide. Besides the limited effect of vaccines, the problem is exac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Hang, Jiang, Ning, Shi, Wenhao, Chi, Xiaojuan, Liu, Sairu, Chen, Ji-Long, Wang, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913928/ https://www.ncbi.nlm.nih.gov/pubmed/33557246 http://dx.doi.org/10.3390/molecules26040810

Ejemplares similares

Co-infection of H9N2 Influenza A Virus and Escherichia coli in a BALB/c Mouse Model Aggravates Lung Injury by Synergistic Effects
por: Wang, Song, et al.
Publicado: (2021)

Antiviral Drugs in Influenza
por: Świerczyńska, Magdalena, et al.
Publicado: (2022)

A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
por: Luo, Junhao, et al.
Publicado: (2023)

The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
por: Li, Yanbai, et al.
Publicado: (2023)

Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
por: Batool, Sania, et al.
Publicado: (2023)

The Regulation of Autophagy by Influenza A Virus
por: Zhang, Rong, et al.
Publicado: (2014)

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010)

Characteristics of human infection with avian influenza viruses and development of new antiviral agents
por: Liu, Qiang, et al.
Publicado: (2013)

Influenza and antiviral resistance: an overview
por: Lampejo, Temi
Publicado: (2020)

Influenza antivirals and animal models
por: Caceres, C. Joaquin, et al.
Publicado: (2022)

The host interactome of influenza virus presents new potential targets for antiviral drugs
por: Shaw, Megan L.
Publicado: (2011)

Pandemic influenza: overview of vaccines and antiviral drugs.
por: Cox, Manon M. J.
Publicado: (2005)

Optimizing Distribution of Pandemic Influenza Antiviral Drugs
por: Singh, Bismark, et al.
Publicado: (2015)

Cell-Penetrating Peptides for Antiviral Drug Development
por: Delcroix, Melaine, et al.
Publicado: (2010)

Antiviral Strategies for Pandemic and Seasonal Influenza
por: Hedlund, Maria, et al.
Publicado: (2010)

Clinical Implications of Antiviral Resistance in Influenza
por: Li, Timothy C. M., et al.
Publicado: (2015)

Antiviral Peptides as Anti-Influenza Agents
por: Agamennone, Mariangela, et al.
Publicado: (2022)

Initial activation of STAT2 induced by IAV infection is critical for innate antiviral immunity
por: Li, Xinxin, et al.
Publicado: (2022)

Can Antiviral Drugs Contain Pandemic Influenza Transmission?
por: Becker, Niels G., et al.
Publicado: (2011)

Antiviral Drugs for Influenza and Other Respiratory Virus Infections
por: Aoki, Fred Y.
Publicado: (2015)

Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development
por: Han, Nanyu, et al.
Publicado: (2020)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)

Mayaro Virus: The State-of-the-Art for Antiviral Drug Development
por: Andreolla, Ana Paula, et al.
Publicado: (2022)

Functional Roles of Non-coding RNAs in the Interaction Between Host and Influenza A Virus
por: Sajjad, Nelam, et al.
Publicado: (2021)

Triazavirin—A Novel Effective Antiviral Drug
por: Chupakhin, Oleg N., et al.
Publicado: (2022)

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
por: Wainberg, Mark A., et al.
Publicado: (2010)

Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
por: Nikonov, O. S., et al.
Publicado: (2018)

Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?
por: Duque, Jazmin, et al.
Publicado: (2014)

Potential Impact of Antiviral Drug Use during Influenza Pandemic
por: Gani, Raymond, et al.
Publicado: (2005)

Adenine: an important drug scaffold for the design of antiviral agents
por: Wang, Changyuan, et al.
Publicado: (2015)

Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development
por: Liu, Chia-Lin, et al.
Publicado: (2016)

Approaches to antiviral drug development.
por: Prusoff, W. H., et al.
Publicado: (1989)

The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
por: Stevaert, Annelies, et al.
Publicado: (2016)

Biological Function and Application of Picornaviral 2B Protein: A New Target for Antiviral Drug Development
por: Li, Zengbin, et al.
Publicado: (2019)

Inflammasomes in antiviral immunity: clues for influenza vaccine development
por: Yamazaki, Tatsuya, et al.
Publicado: (2014)

Antivirals for the treatment and prevention of epidemic and pandemic influenza
por: Oxford, John S.
Publicado: (2007)

Perspective of Use of Antiviral Peptides against Influenza Virus
por: Skalickova, Sylvie, et al.
Publicado: (2015)

The Antiviral Role of Galectins toward Influenza A Virus Infection—An Alternative Strategy for Influenza Therapy
por: Lin, Chih-Yen, et al.
Publicado: (2021)

Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome
por: Wang, Song, et al.
Publicado: (2016)

Antiviral Effects of Animal Toxins: Is There a Way to Drugs?
por: Utkin, Yuri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v7sr2q2i9c8mr3r90m692diadd